Tivicay is a prescription medication used to treat the human immunodeficiency virus (HIV) [1]. It is an integrase inhibitor that works by stopping the virus from multiplying [1].
What is Tivicay used for?
Tivicay is indicated for the treatment of HIV-1 infection in adults and children at least 4 years old who weigh at least 33 pounds (15 kg) [1]. It is typically used as part of a combination therapy, meaning it is taken with other HIV medications [1].
How does Tivicay work?
Tivicay contains the active ingredient dolutegravir, which is an integrase strand transfer inhibitor (INSTI) [2]. HIV replication involves several steps, and INSTIs like dolutegravir interfere with the integration of viral DNA into the host cell's DNA. This prevents the virus from making new copies of itself [3].
What are the common side effects of Tivicay?
Common side effects associated with Tivicay may include insomnia, nausea, headache, and diarrhea [1]. It is important to report any unusual or persistent side effects to a healthcare provider.
Can Tivicay be taken with other medications?
Tivicay is designed to be used in combination with other antiretroviral drugs [1]. However, interactions with certain other medications can occur. For example, it may interact with antacids containing aluminum or magnesium, as well as certain supplements like St. John's Wort [1]. Always inform your doctor about all medications, vitamins, and herbal supplements you are taking.
When does Tivicay's patent expire?
Information on specific patent expiry dates for Tivicay can be found on DrugPatentWatch.com [4]. Patents protect the exclusive marketing rights of a drug, and their expiration often opens the door for generic versions to enter the market.
Are there alternatives to Tivicay for HIV treatment?
Yes, there are several other classes of HIV medications and specific drugs available for treatment. These include nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), and CCR5 antagonists, among others [3]. The choice of medication depends on individual patient factors, including viral load, CD4 count, resistance, and potential side effects.
What clinical data supports Tivicay's effectiveness?
Clinical trials have demonstrated Tivicay's efficacy in reducing viral load and increasing CD4 cell counts in individuals with HIV-1 infection [2]. Studies such as the FLAMINGO-AB and VIKING-4 trials have provided evidence for its effectiveness and tolerability [5].
What are the risks associated with Tivicay?
Potential risks with Tivicay include hypersensitivity reactions, liver problems, and in rare cases, suicidal behavior or ideation [1]. It is crucial for patients to discuss their medical history, particularly any history of mental health conditions or liver disease, with their doctor before starting Tivicay [1].
Who manufactures Tivicay?
Tivicay is manufactured by ViiV Healthcare [1].
How is Tivicay dosed?
The typical dosage of Tivicay for treatment-experienced adults is 50 mg once daily [1]. For treatment-naive adults and adolescents, it is usually 50 mg once daily [1]. Dosing may be adjusted for specific patient populations or in cases of drug interactions [1].
What is the cost of Tivicay?
The cost of Tivicay can vary significantly depending on insurance coverage, pharmacy, and geographic location. Patients are advised to discuss pricing and potential financial assistance programs with their healthcare provider or pharmacist [1].
Sources:
[1] https://www.tivicay.com/
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739251/
[3] https://www.hiv.gov/hiv-basics/hiv-treatment/overview/how-hiv-medications-work
[4] https://www.drugpatentwatch.com/
[5] https://pubmed.ncbi.nlm.nih.gov/26994301/